Literature DB >> 17618774

Sacral nerve neuromodulation in patients with cardiac pacemakers.

Patricia A Wallace1, Felicia L Lane, Karen L Noblett.   

Abstract

OBJECTIVE: The objective of the study was to describe our experience using sacral nerve neuromodulation for urinary urgency, frequency, and urge incontinence in patients with cardiac pacemakers. STUDY
DESIGN: The study was a case series of 3 patients with cardiac pacemakers who underwent sacral nerve stimulation for refractory urgency, frequency, and urge incontinence.
RESULTS: Each patient underwent placement of an InterStim lead wire in the S3 foramen. Intraoperative cardiac monitoring revealed no evidence of cross-interference, even at maximum stimulation. Postoperative telemetry for 24 hours did not reveal any interference from the sacral nerve stimulator. All patients had a greater than 50% reduction in incontinence episodes during their test trial and underwent placement of the InterStim implantable pulse generator (IPG). Intraoperative and postoperative IPG programming was done with cardiac monitoring; no interaction was detectable.
CONCLUSION: Sacral nerve stimulation appears to be safe in the presence of a cardiac pacemaker.

Entities:  

Mesh:

Year:  2007        PMID: 17618774     DOI: 10.1016/j.ajog.2007.04.017

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

1.  Sacral neuromodulation and cardiac pacemakers.

Authors:  Ted M Roth
Journal:  Int Urogynecol J       Date:  2010-01-30       Impact factor: 2.894

Review 2.  Sacral nerve stimulation in the elderly.

Authors:  Tomas L Griebling
Journal:  Int Urogynecol J       Date:  2010-12       Impact factor: 2.894

Review 3.  [The future of invasive neuromodulation: new techniques and expanded indications].

Authors:  A van Ophoven; J Pannek
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

4.  Sacral Neuromodulation in Patients With a Cardiac Pacemaker.

Authors:  Abdullah A Gahzi; Dean S Elterman; Magdy Hassouna
Journal:  Int Neurourol J       Date:  2016-09-23       Impact factor: 2.835

5.  Sacral Neuromodulation in a Patient with Wolff-Parkinson-White Syndrome: A Case Report.

Authors:  Sulaiman Almutairi
Journal:  Res Rep Urol       Date:  2020-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.